Clinical Research: How to Use Risk-Based Monitoring and Clinical Corrective Action and Preventative Action (CAPA) to Ensure Compliance

It’s estimated that the average cost of developing a new drug has increased from $1 billion in 2010 to $1.1 billion in 2012. A big part of the cost can be attributed to clinical research, which typically lasts at least eight-and-a-half years. Given the enormous cost, time, and effort involved in clinical research, sponsors and […]